{"id":"atacicept-with-loading-dose","safety":{"commonSideEffects":[{"rate":"10%","effect":"Injection site reaction"},{"rate":"20%","effect":"Headache"},{"rate":"15%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL1742986","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Atacicept is a recombinant protein that blocks the interaction between CD28 and B7 molecules, thereby inhibiting T-cell activation and proliferation.","oneSentence":"CD28/B7 costimulation blockade","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:21:39.026Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Rheumatoid arthritis"}]},"trialDetails":[{"nctId":"NCT00853762","phase":"PHASE2","title":"Atacicept in Multiple Sclerosis Extension Study, Phase II","status":"TERMINATED","sponsor":"EMD Serono","startDate":"2009-03","conditions":"Relapsing Multiple Sclerosis","enrollment":74},{"nctId":"NCT00642902","phase":"PHASE2","title":"A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS)","status":"TERMINATED","sponsor":"EMD Serono","startDate":"2008-04","conditions":"Relapsing Multiple Sclerosis","enrollment":255},{"nctId":"NCT00624338","phase":"PHASE2, PHASE3","title":"Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2008-01","conditions":"Lupus Erythematosus, Systemic","enrollment":461},{"nctId":"NCT00624468","phase":"PHASE2","title":"Atacicept in Subjects With Optic Neuritis","status":"TERMINATED","sponsor":"EMD Serono","startDate":"2008-06","conditions":"Optic Neuritis","enrollment":34},{"nctId":"NCT00595413","phase":"PHASE2","title":"Atacicept in Anti-Tumor Necrosis Factor Alpha-naïve Subjects With Rheumatoid Arthritis (AUGUST II)","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2007-09","conditions":"Rheumatoid Arthritis","enrollment":311},{"nctId":"NCT00430495","phase":"PHASE2","title":"A Phase 2 Dose-finding Study of Atacicept in Subjects With Rheumatoid Arthritis (AUGUST I)","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2006-12","conditions":"Rheumatoid Arthritis","enrollment":256}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Atacicept: with loading dose","genericName":"Atacicept: with loading dose","companyName":"EMD Serono","companyId":"emd-serono","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CD28/B7 costimulation blockade Used for Rheumatoid arthritis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}